Behind the Innovation
Setting Science in Motion
Everything we do at Avantor is designed to set science in motion, from our scientists collaborating with customers at our Innovation Centers to our analytics capabilities, to our ultra-high purity ingredients. Check out our innovation stories.
What started as a straightforward mandate to Avantor’s Bridgewater Innovation Center scientists – to find an eco-friendly alternative to a leading bioprocessing detergent – transformed into a challenge to bring improved efficiencies and cost savings to customers during downstream bioprocessing for both gene and mAb therapies.
Catherine Teo, Senior Research Scientist, explains how her team at Avantor's Bridgewater Innovation Center is focused on discovering, developing and delivering solutions to help the biopharma industry improve production for biological products, such as antibodies, mRNA, or recombinant proteins.
Avantor NuSil® R&D Scientist Sandra Ortega shares her path to a career in research and discusses developing high-purity silicone applications for the medical devices, aerospace exploration and defense system industries.
James Hwang, Head of Biopharma Applications for Asia, Middle East and Africa, shares insights on the downstream production challenges his Avantor Innovation Center teams in South Korea, Singapore and India tackle with partners in the biopharma industry.
Avantor’s Tola Olorunnisola and Philippe De Winne discuss how deploying AI for inventory management gives scientists more time back to focus on innovations
Ger Brophy, Chair of Avantor’s Scientific Advisory Board, looks in-depth at optimizing viral vector production and collaborating on industry standardization and automation.
Tola Olorunnisola, senior vice president and general manager for services at Avantor, delves into how AI and automation could put the Lab of the Future within our grasp, enabling scientific breakthroughs and revolutionizing drug development.
In this The Restless Ones podcast, Avantor’s Chief Information Officer, Mike Wondrasch, discusses how Avantor uses connectivity, data, and computing power to “set science in motion to create a better world.”
Avantor’s Mark Featherston and John D. Fisher discuss how digitalization increasingly enables biopharma companies to collect and analyze large datasets and recommend improvements.